Oprah Winfrey reveals weight loss secret

Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.
Oprah Winfrey faces backlash for making bold claim about ‘thin people’ after taking weight-loss drug
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.
Oprah Winfrey Says Her Opinion of ‘Thin People’ Changed After She Used Weight Loss Drugs
Oprah Winfrey is opening up about the revelation she had about “thin people.” On the Jan. 14 episode of The Oprah Podcast, the former talk show host had a conversation with Yale University obesity medicine physician scientist Dr.
Oprah Winfrey reveals shocking discovery after using weight-loss drug: 'They are not even thinking about it'
Oprah Winfrey is opening up about her experience using weight-loss drugs. The media mogul is sharing some of the realizations she has found after being under an undisclosed GLP-1, which is a type 2 diabetes medication that results in weight loss.
What changed Oprah Winfrey’s perception of thin people
Oprah Winfrey has changed her perceptions of "thin people" after taking weight loss medication. The 70-year-old talk show host has seen her
Oprah Winfrey says Ozempic allowed her to realize the truth about 'thin people'
In the latest episode of her podcast, Winfrey opened up about how taking weight loss drugs have changed her view on obesity
Oprah on taking Ozempic: ‘Weight loss drug is not taking easy way out’
In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other medical conditions.
Diabetes startup Virta Health is now prescribing Ozempic for weight loss in a push toward profitability and IPO
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
New Scientist on MSN1d
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
phillyvoice.com1d
Ozempic and Wegovy are helping many Americans lose weight, but they also may have other beneficial uses
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
Demand for loose skin surgery rises with GLP-1 weight loss meds
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Can't Afford Ozempic? A Complete Guide to Other Effective Weight Loss Alternatives
Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Ozempic May Damage Vital Organs, Study Finds
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...